NCT00967824View on ClinicalTrials.gov

Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1,683

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2008

Conditions
Breast Cancer
Interventions
OTHER

informational intervention

OTHER

questionnaire administration

OTHER

survey administration

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00967824 - Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer | Biotech Hunter | Biotech Hunter